Announcements

Cleansing Notice – Rights Issue

Opyl Completes Placement And Launches Rights Issue

Opyl delivers world-first in mapping and linking global clinical trial outcome data

Opyl receives $570K R&D tax refund

Clarification to ASX announcement of 28 September 2022

Opin forms strategic partnership and new services for better clinical trial outcomes and scale

Opyl Full Year FY22 Results Announcement

Opyl partners with leading patient advocate groups

Opyl signs two clinical trial recruitment contracts

Opyl receives $361K R&D tax refund

Opyl Director Mr Basyrov steps down

Notice of 2021 Annual General Meeting